HC Wainwright & Co. Initiates Coverage On Sophia Genetics with Buy Rating, Announces Price Target of $12

Benzinga Newsdesk www.benzinga.com Neutral 74.6%

Neg 0% Neu 74.6% Pos 0%

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Sophia Genetics (NASDAQ:SOPH) with a Buy rating and announces Price Target of $12.